Emergent BioSolutions, Inc. (EBS)
8.15
+0.09
(+1.12%)
USD |
NYSE |
May 20, 16:00
8.10
-0.05
(-0.61%)
After-Hours: 19:42
Emergent BioSolutions Shareholders Equity (Quarterly) : 523.10M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Savara, Inc. | 176.04M |
| Biogen, Inc. | 18.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.320B |
| Total Liabilities (Quarterly) | 797.30M |
| Debt to Equity Ratio | 1.214 |
| Current Ratio | 4.288 |
| Net Debt Paydown Yield | 1.91% |